tiprankstipranks
IMARA (IMRA)
NASDAQ:IMRA
US Market

IMARA Stock Price & Analysis

226 Followers

IMRA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.97 - $4.36
Previous Close$2.11
Volume300.00K
Average Volume (3M)2.65M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$60.34M
Total Debt (Recent Filing)$246.00K
P/E Ratio-1.0
Beta0.96
Next EarningsNov 09, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-2.08
Shares Outstanding26,287,264
R-Squared0.12
Standard Deviation0.28
10 Day Avg. Volume596,408
30 Day Avg. Volume2,649,138
P/B Ratio0.90
P/S RatioN/A
P/CF RatioN/A
P/FCF Ratio-1.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusHold
Alpha-0.08
Number of Analyst Covering1


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

IMRA FAQ

What was IMARA’s price range in the past 12 months?
IMARA lowest stock price was $0.97 and its highest was $4.36 in the past 12 months.
    What is IMARA’s market cap?
    Currently, no data Available
    When is IMARA’s upcoming earnings report date?
    IMARA’s upcoming earnings report date is Nov 09, 2022 which is in 42 days.
      How were IMARA’s earnings last quarter?
      IMARA released its earnings results on Aug 19, 2022. The company reported -$0.438 earnings per share for the quarter, missing the consensus estimate of -$0.428 by -$0.01.
        Is IMARA overvalued?
        According to Wall Street analysts IMARA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does IMARA pay dividends?
          IMARA does not currently pay dividends.
          What is IMARA’s EPS estimate?
          IMARA’s EPS estimate is -$0.29.
            How many shares outstanding does IMARA have?
            IMARA has 26,275,723 shares outstanding.
              What happened to IMARA’s price movement after its last earnings report?
              IMARA reported an EPS of -$0.438 in its last earnings report, missing expectations of -$0.428. Following the earnings report the stock price went down -1.724%.
                Which hedge fund is a major shareholder of IMARA?
                Among the largest hedge funds holding IMARA’s share is RA Capital Management. It holds IMARA’s shares valued at N/A.

                  ---

                  IMARA Stock Analysis

                  Smart ScoreNeutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  4
                  The IMARA stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  IMARA

                  Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Johnson & Johnson
                  Eli Lilly & Co
                  Pfizer
                  Merck & Company
                  Bristol Myers

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis